M&T Bank Corporation to Participate in the RBC Capital Markets US Banks Fixed Income Investor Symposium
M&T Bank Corporation to Participate in the RBC Capital Markets US Banks Fixed Income Investor Symposium
PR Newswire
BUFFALO, N.Y., April 24, 2024
BUFFALO, N.Y., April 24, 2024 /PRNewswire/ -- M&T Bank Corporation ("M&T") (NYSE:MTB) will participate in the RBC Capital Markets US Banks Fixed Income Investor Symposium. Representatives of M&T will meet with investors in New York City on April 30, Chicago on May 1 and virtually on May 2.
About M&T
M&T Bank Corporation is a financial holding company headquartered in Buffalo, New York. M&T's principal banking subsidiary, M&T Bank, provides banking products and services in 12 states across the eastern U.S. from Maine to Virginia and Washington, D.C. Trust-related services are provided in select markets in the U.S. and abroad by M&T's Wilmington Trust-affiliated companies and by M&T Bank.
Investor Contact:
Brian Klock
(716) 842-5138
View original content to download multimedia:https://www.prnewswire.com/news-releases/mt-bank-corporation-to-participate-in-the-rbc-capital-markets-us-banks-fixed-income-investor-symposium-302126754.html
SOURCE M&T Bank Corporation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?